orbofiban has been researched along with thrombin receptor peptide sfllrnp in 1 studies
Studies (orbofiban) | Trials (orbofiban) | Recent Studies (post-2010) (orbofiban) | Studies (thrombin receptor peptide sfllrnp) | Trials (thrombin receptor peptide sfllrnp) | Recent Studies (post-2010) (thrombin receptor peptide sfllrnp) |
---|---|---|---|---|---|
48 | 17 | 0 | 92 | 10 | 29 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feuerstein, GZ; Friedman, SM; Gibbs, SK; Racanelli, AL; Seiffert, DA; Zondlo, SC | 1 |
1 other study(ies) available for orbofiban and thrombin receptor peptide sfllrnp
Article | Year |
---|---|
Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro.
Topics: Adenosine Diphosphate; Alanine; Blood Platelets; Humans; In Vitro Techniques; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Time Factors | 2003 |